AI Tool Comparison
Comparing as AI Medical Imaging & DiagnosticsPaige vs Aidoc
Paige
VS
Aidoc
Verdict by Category
Detailed Comparison
Feature
Paige
Aidoc
Pricing
EnterprisePaige operates exclusively on enterprise contracts with hospital pathology departments, cancer centers, and biopharma companies. There is no published pricing or self-serve option.
Clinical deployments are priced based on institution size, scanner ecosystem, patient volume, and AI modules deployed (FullFocus, Paige Prostate, Paige Breast, etc.). Biopharma partnerships are structured as research service agreements for biomarker discovery, companion diagnostic development, and drug trial tissue analysis.
Contact Paige through paige.ai to arrange an enterprise discovery call and platform demonstration.
CustomAidoc operates on enterprise contracts with hospitals and health systems — there is no published pricing or self-serve option. Pricing is customized based on hospital size, imaging volume, number of AI algorithms deployed, and integration complexity.
Health systems engage through Aidoc's enterprise sales team, who assess needs, design a deployment plan, and structure a contract that typically includes implementation, onboarding, and ongoing support. Aidoc's BRIDGE framework with NVIDIA supports scalable rollout across multi-site health systems.
Contact Aidoc directly at aidoc.com to request a demo or begin the enterprise procurement process.
Categories
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare ToolsAI Research & Education Tools
Summary
Computational pathology AI from MSK — the first FDA-cleared platform for AI-assisted cancer diagnosis
Clinical AI platform for radiology triage — FDA-cleared algorithms detecting acute conditions in 2,000+ hospitals
Paige Pros & Cons
Pros
- First FDA clearance for AI in primary pathology diagnosis — a historic regulatory milestone
- First CE mark for AI pathology in Europe — validated for clinical use across EU
- Founded on MSK's 25M+ pathology slides — the richest cancer pathology training set in the world
- AIRI infrastructure with 10+ petaFLOPS — enterprise-grade AI compute at clinical scale
- FullFocus viewer is scanner-neutral with FDA clearances for Leica, Hamamatsu, and Philips
- The most credentialed AI pathology company in terms of regulatory approvals
- Backed by Goldman Sachs, Breyer Capital, and Healthcare Venture Partners
Cons
- Enterprise and institutional access only — not available to small or independent pathology labs
- No published pricing — all contracts negotiated through enterprise procurement
- Requires digital pathology infrastructure — scanners, storage, and LIS integration
- Pathologist review and sign-off still required for all AI-generated results
- Focused on pathology and oncology — not a general medical imaging platform
Aidoc Pros & Cons
Pros
- Deployed in nearly 2,000 hospitals — the most widely adopted AI radiology platform globally
- 60M+ patient cases analyzed annually — proven at massive scale
- $534M raised — one of the best-funded medical AI companies in the world
- Dozens of FDA clearances — most extensively cleared AI imaging portfolio available
- PACS-agnostic — works with any existing radiology infrastructure
- Gartner Cool Vendor and named in multiple industry AI leadership reports
- CARE1 foundation model and BRIDGE/NVIDIA framework for next-gen AI deployment
Cons
- Enterprise-only — not available for small clinics or independent radiologists
- No published pricing — requires sales engagement for quotes
- Requires integration with existing PACS and EHR infrastructure
- Deployment and onboarding can take weeks to months for large systems
- AI recommendations still require radiologist review and sign-off